Log in to save to my catalogue

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1773833239

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

About this item

Full title

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2016-01, Vol.113 (4), p.E459-E468

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Chimeric antigen receptor T (CAR-T) cell therapy has produced impressive results in clinical trials for B-cell malignancies. However, safety concerns related to the inability to control CAR-T cells once infused into the patient remain a significant challenge. Here we report the engineering of recombinant antibody-based bifunctional switches that co...

Alternative Titles

Full title

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1773833239

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1773833239

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1524155113

How to access this item